Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells

Oncogene volume 21, pages 2212–2226 (2002)Cite this article

Abstract

Evidence indicates that overexpression of cyclin D1 is an important event in malignant transformation of breast cancer cells. Therefore, cyclin D1 is a potential target for mechanistically-based chemoprevention/treatment of breast cancer. Treatment of serum-stimulated quiescent MCF-7 breast cancer cells with cyclopentenone (2-cyclopenten-1-one) blocked progression through G1 and into S phase. Growth arrest of the cyclopentenone-treated cells in G1 was associated with changes in the levels of several proteins that control the cell cycle, including a dramatic decrease in cyclin D1 protein expression. Cyclopentenone also decreased the abundance of cyclin D1 mRNA and nuclear transcripts, indicating that it regulated cyclin D1 expression at the transcriptional level. Cyclopentenone selectively inhibited the activity of the cyclin D1 and cyclin A promoters but not the activity of several other control promoters. Deletion analysis indicated that the cyclopentenone response element was located in the cyclin D1 core promoter. Additional functional studies showed that a sequence within the core promoter (CycY, located downstream from the initiator element) played an important role in activation of the cyclin D1 promoter in MCF-7 cells. Electrophoretic mobility shift assays demonstrated specific binding of the transcription factor BTEB to the CycY site. The cyclopentenone response element did not correspond to the CycY site but rather mapped to the initiator element itself. The overall results suggest that cyclopentenone interferes with the transcription initiation complex that assembles over the cyclin D1 initiator element, leading to selective inhibition of cyclin D1 gene transcription.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12

Similar content being viewed by others

References

  • Alle KM, Henshall SM, Field AS, Sutherland RL . 1998 Clin. Cancer Res. 4: 847–854

  • Baker RT, Board PG . 1989 Am. J. Hum. Genet. 44: 534–542

  • Barnes DM . 1997 J. Pathol. 181: 267–269

  • Briggs MR, Kadonaga JT, Bell SP, Tjian R . 1986 Science 234: 47–52

  • Bui T, Kuo C, Rotwein P, Straus DS . 1997 Endocrinol. 138: 985–993

  • Bui T, Straus DS . 1998 Biochimi. Biophys. Acta 1397: 31–42

  • Chen A, Davis BH . 1999 J. Biol. Chem. 274: 158–164

  • Ciufolini MA, Zhu S . 1998 J. Org. Chem. 63: 1668–1675

  • Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C . 1995 Genes Dev. 9: 2364–2372

  • Fukami-Kobayashi J, Mitsui Y . 1998 Exp. Cell Res. 241: 435–444

  • Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G, Barnes D . 1996 Int. J. Cancer 69: 92–99

  • Gillett CE, Lee AH, Millis RR, Barnes DM . 1998 J. Pathol. 184: 396–400

  • Gorospe M, Liu Y, Xu Q, Chrest FJ, Holbrook NJ . 1996 Mol. Cell. Biol. 16: 762–770

  • Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC . 1999 Cell 98: 859–869

  • Hayden JM, Marten NW, Burke EJ, Straus DS . 1994 Endocrinol. 134: 760–768

  • Herber B, Truss M, Beato M, Muller R . 1994 Oncogene 9: 1295–1304

  • Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . 1999 Mol. Cell. Biol. 19: 2690–2698

  • Hsiang C-H, Marten NW, Straus DS . 1999 Biochem. J. 338: 241–249

  • Imataka H, Sogawa K, Yasumoto K, Kikuchi Y, Sasano K, Kobayashi A, Hayami M, Fujii-Kuriyama Y . 1992 EMBO J. 11: 3663–3671

  • Jiang G, Nepomuceno L, Hopkins K, Sladek FM . 1995 Mol. Cell. Biol. 15: 5131–5143

  • Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G . 1991 Oncogene 6: 439–444

  • Lania L, Majello B, De Luca P . 1997 Int. J. Biochem. Cell Biol. 29: 1313–1323

  • Lin S, Wang W, Wilson GM, Yang X, Brewer G, Holbrook NJ, Gorospe M . 2000 Mol. Cell. Biol. 20: 7903–7913

  • Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I . 1998 J. Biol. Chem. 273: 33508–33516

  • Marten NW, Burke EJ, Hayden JM, Straus DS . 1994 FASEB J. 8: 538–544

  • Marten NW, Hsiang C-H, Yu L, Stollenwerk NS, Straus DS . 1999 Biochimi. Biophys. Acta 1447: 160–174

  • Martin KM, Cooper WN, Metcalfe JC, Kemp PR . 2000 Biochem. J. 345: 529–533

  • Matsushime H, Roussel MF, Ashmun RA, Sherr CJ . 1991 Cell 65: 701–713

  • McInerney EM, Rose DW, Flynn SE, Westin S, Mullen T-M, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG . 1998 Genes Dev. 12: 3357–3368

  • Morgan DO . 1995 Nature 374: 131–134

  • Motokura T, Arnold A . 1993 Genes Chromosomes Cancer 7: 89–95

  • Nenoi M, Mita K, Ichimura S, Cartwright IL, Takahashi E-I, Yamauchi M, Tsuji H . 1996 Gene 175: 179–185

  • Nielsen SJ, Praestegaard M, Jorgensen HF, Clark BF . 1998 Biochem. J. 333: 511–517

  • O'Brien T, Tjian R . 2000 Proc. Natl. Acad. Sci. USA 97: 2456–2461

  • Phillip A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M . 1994 Mol. Cell. Biol. 14: 4032–4043

  • Rossi A, Elia G, Santoro MG . 1996 J. Biol. Chem. 271: 32192–32196

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA . 1995 Cell 82: 621–630

  • Simpson JF, Quan DE, O'Malley F, Odom-Maryon T, Clarke PE . 1997 Am. J. Pathol. 151: 161–168

  • Smale ST . 1997 Biochimi. Biophys. Acta 1351: 73–88

  • Smale ST . 2001 Genes Dev. 15: 2503–2508

  • Smith R, Peters G, Dickson C . 1995 Genomics 25: 85–92

  • Straus DS, Burke EJ, Marten NW . 1993 Endocrinol. 132: 1090–1100

  • Straus DS, Marten NW, Hayden JM, Burke EJ . 1994 J. Nutr. 124: 1041–1051

  • Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK . 2000 Proc. Natl. Acad. Sci. USA 97: 4844–4849

  • Straus DS, Glass CK . 2001 Medicinal Res. Rev. 21: 185–210

  • Suh N, Wang Y, Honda T, Gribble GW, Dmitrovsky E, Hickey WF, Maue RA, Place AE, Porter DM, Spinella MJ, Williams CR, Wu G, Dannenberg AJ, Flanders KC, Letterio JJ, Mangelsdorf DJ, Nathan CF, Nguyen L, Porter WW, Ren RF, Roberts AB, Roche NS, Subbaramaiah K, Sporn MB . 1999 Cancer Res. 59: 336–341

  • Suzuki-Yagawa Y, Guermah M, Roeder RG . 1997 Mol. Cell. Biol. 17: 3284–3294

  • Taylor WR, Stark GR . 2001 Oncogene 20: 1803–1815

  • Wang EH, Tjian R . 1994 Science 263: 811–814

  • Wang EH, Zou S, Tjian R . 1997 Genes Dev. 11: 2658–2669

  • Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV . 1994 Nature 369: 669–671

  • Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG . 1998 Mol. Cell. Biol. 18: 3212–3222

  • Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS . 1995 Nature Med. 1: 1257–1260

  • Xiong Y, Connolly T, Futcher B, Beach D . 1991 Cell 65: 691–699

  • Xiong Y, Menninger J, Beach D, Ward DC . 1992 Genomics 13: 575–584

  • Yu Q, Geng Y, Sicinski P . 2001 Nature 411: 1017–1021

  • Zhou Q, Stetler-Stevenson M, Steeg PS . 1997 Oncogene 15: 107–115

Download references

Acknowledgements

We thank the colleagues named in the Materials and methods section who provided DNA constructs used in the present project and E Martinez for helpful comments on the manuscript. This research was supported by Department of Defense Breast Cancer Grant DAMD17-99-1-9102.

Author information

Authors and Affiliations

  1. Biomedical Sciences Division and Biology Department, University of California, Riverside, 92521-0121, California, CA, USA

    Chin-Hui Hsiang & Daniel S Straus

Authors
  1. Chin-Hui Hsiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel S Straus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel S Straus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsiang, CH., Straus, D. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells. Oncogene 21, 2212–2226 (2002). https://doi.org/10.1038/sj.onc.1205293

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205293

Keywords

This article is cited by

Search

Advanced search

Quick links